You're browsing HLTH 2018's website. Visit hlth.com to explore this year's edition!

Main caricature of Thomas Clozel, who is speaking at HLTH and is CEO at OWKIN Overlay caricature of Thomas Clozel, who is speaking at HLTH and is CEO at OWKIN

Thomas Clozel

CEO

OWKIN



Thomas Clozel, M.D, M.S is a former assistant professor of oncology/hematology in Paris, and had co lead different projects focused of prediction of resistance to chemotherapy and ways to reverse it at Weill Cornell Medical College. He co founded OWKIN with Gilles Wainrib in June 2016 to bring the power of machine learning prediction to any doctor or researcher and improve development and use of new drugs. OWKN is the first beyond AI company to use federated learning and blockchain into every algorithm to create collaborations, safety, and traceability among all user and data. Thomas now lives in New York.